Search
States like Colorado are experimenting with Prescription Drug Affordability Boards to address the price of medicine, but solutions like Upper Payment Limits will yield multiple unintended consequences that will do more harm than good to patients.
Read More
Some employers are “saving money” on health insurance by hiring vendors to broker personal drug importation between their employees and unlicensed, illegal foreign pharmacies. Read more to understand the dangers of this cost-cutting practice.
Read More
PBMs, by under reimbursing pharmacies, are creating a demand for pharmacies to seek lower priced medications even when they can’t exist at that price.. Criminals appear to be happy to become part of the supply chain.
Read More
FDA continues to investigate counterfeit Ozempic (semaglutide) injection 1 milligram (mg) in the legitimate U.S. drug supply chain and has seized thousands of units of the product. FDA is aware of five adverse events from this lot.
Read More
A CNBC story covered details about Lazaro Hernandez’s $230 million HIV drug diversion scheme. A recent survey showed that Americans don’t understand online pharmacy safety. More news about counterfeit medicines across the globe.
Read More
It isn’t just U.S. regulators that warn against ordering medicines from unlicensed pharmacies. Canadian regulators have the same concerns about the safety of unapproved medical products.
Read More
FDA warned about contamination in 26 different over-the-counter eye drops. Ten New York residents were indicted in another black market HIV medicine scheme. Additional stories in California, Florida, and Texas.
Read More
The FDA is cracking down on lax safety testing of raw drug ingredients. Major players in HIV drug and cough syrup counterfeiting schemes pleaded guilty in federal court.
Counterfeit Avastin in Pakistan blinded over 70 retinopathy patients.
CBP at JFK Airport intercepted 14 pairs of pill press dies. Additional news about illicit pill presses in five states.
Read More
USFDA is concerned that eight companies, including two pharmacies, are illegally marketing unapproved ophthalmic drug products that pose a heightened risk to users. Counterfeit pills make the DHS’ threat assessment list for 2024.
Read More
On June 16, 2023 Novo Nordisk warned that a fake version of the diabetes drug Ozempic had been found in the U.S. The injection pen, which contained insulin instead of semaglutide, was reportedly purchased at a retail pharmacy. It’s one of a flurry of incidents involving Ozempic and its sister drugs.
Read More